Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 229-235, October 2009

Breast Conservation Therapy for Patients With Locally Advanced Breast Cancer

  • Mohamed A. Alm El-Din, MD

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    • Department of Radiation Oncology, Tanta University Hospitals, Tanta Faculty of Medicine, Tanta, Egypt
  • ,
  • Alphonse G. Taghian, MD, PhD

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Alphonse G. Taghian, MD, PhD, Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street Cox Building 302, Boston, MA 02114

Neoadjuvant chemotherapy achieves high response rates in patients with breast cancer and has been used to reduce tumor size and allow for breast conservation in individuals who initially required mastectomy. The goals of this approach are to achieve optimal locoregional control together with acceptable cosmesis. In the setting of locally advanced disease, breast preservation appears to be feasible for appropriately selected patients whose tumors show adequate downstaging in response to induction chemotherapy. Nevertheless, further prospective randomized trials are warranted to better evaluate the results of this approach as compared with mastectomy.

Keywords: breast cancer, locally advanced, breast conservation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(09)00043-5

doi:10.1016/j.semradonc.2009.05.005

Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 229-235, October 2009